By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AEterna Zentaris 

1405 Boul Du Parc-technologique

Quebec  Quebec  G1P 4P5  Canada
Phone: 418-652-8525 Fax: 418-652-0881


SEARCH JOBS








Company News
AEterna Zentaris (AEZS) Announces Optimized Erk Inhibitor Compounds For Further Development 7/30/2015 10:10:05 AM
AEterna Zentaris (AEZS) Grants Option To Develop And Commercialize Oral Allogenic Cancer Vaccine Technology 7/28/2015 11:11:53 AM
AEterna Zentaris (AEZS) Commences Promotional Activities For EMD Serono's Saizen [Somatropin (rDNA origin) For Injection] 7/27/2015 10:18:59 AM
ErgoMed’s Co-Development Partner AEterna Zentaris (AEZS) Completes Patient Recruitment For Zoptec Phase 3 Study With Zoptarelin Doxorubicin In Advanced Endometrial Cancer 6/30/2015 9:56:46 AM
AEterna Zentaris (AEZS) Completes Patient Recruitment For ZoptEC Phase 3 Study With Zoptarelin Doxorubicin In Advanced Endometrial Cancer 6/30/2015 6:38:09 AM
ErgoMed Selected By Co-Development Partner AEterna Zentaris (AEZS) To Conduct Confirmatory Phase 3 Clinical Trial Of Macrilen In AGHD 6/25/2015 10:06:41 AM
AEterna Zentaris (AEZS) Announces Selection Of ErgoMed To Conduct Confirmatory Phase 3 Clinical Trial Of Macrilen In AGHD 6/25/2015 6:20:20 AM
AEterna Zentaris (AEZS) Announces Extension To Regain Compliance With NASDAQ's Minimum Bid Price Rule 6/18/2015 6:30:31 AM
AEterna Zentaris (AEZS)' Confirmatory Phase 3 Study for Macrilen In AGHD Meets European Medicines Agency's Study-Design Expectations 5/26/2015 6:15:53 AM
AEterna Zentaris (AEZS) Announces Election Of Directors At 2015 Shareholders' Meeting 5/11/2015 4:33:56 PM
12345678910...
//-->